Proposal for Extending The Classification of Adult Myelodysplastic Syndromes (Mds) To Pediatrics Mds

被引:0
|
作者
P L Greenberg
机构
[1] Stanford & Palo Alto VA Medical Centers,
来源
Pediatric Research | 1999年 / 45卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:746 / 746
相关论文
共 50 条
  • [41] Assessing the Prognosis of Patients with Myelodysplastic Syndromes (MDS)
    Kasprzak, Annika
    Nachtkamp, Kathrin
    Gattermann, Norbert
    Germing, Ulrich
    CANCERS, 2022, 14 (08)
  • [42] Treatment of Lower Risk Myelodysplastic Syndromes MDS
    Komrokji, Rami
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S69 - S70
  • [43] THE VALUE OF SCORING SYSTEMS IN MYELODYSPLASTIC SYNDROMES (MDS)
    KRIEGER, O
    BERNHART, M
    KASPARU, H
    KOLLER, U
    NOWOTNY, H
    TUCHLER, H
    LUTZ, D
    BLUT, 1988, 56 (06): : C13 - C13
  • [44] Management of older adults with myelodysplastic syndromes (MDS)
    Luskin, Marlise R.
    Abel, Gregory A.
    JOURNAL OF GERIATRIC ONCOLOGY, 2018, 9 (04) : 302 - 307
  • [45] Intensive chemotherapy with quinine in myelodysplastic syndromes (MDS).
    Wattel, E
    Solary, E
    Caillot, D
    Dreyfus, F
    Brion, A
    Mahe, B
    HoangNgoc, L
    Maloisel, F
    Guerci, A
    Rochant, H
    Gratecos, N
    Sadoun, A
    Stamatoullas, A
    Casassus, P
    Janvier, M
    Stoppa, AM
    Desablens, B
    Fegeux, N
    Ifrah, N
    Abgrall, JP
    Guyotat, D
    Dupriez, B
    Peny, AM
    Brice, P
    Pignon, B
    Leporrier, M
    Lepelley, P
    Fenaux, P
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 34 - 34
  • [46] In vitrodevelopment of haemopoietic progenitors in myelodysplastic syndromes (MDS)
    S Tauro
    DT Bowen
    SJL Brada
    JThM de Wolf
    DW Hendriks
    JW Smit
    E Vellenga
    Leukemia, 1999, 13 : 494 - 495
  • [47] INTENSIVE CHEMOTHERAPY FOR PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    BERNSTEIN, SH
    BRUNETTO, VL
    DAVEY, FR
    MAYER, RJ
    WURSTERHILL, D
    SCHIFFER, CA
    BLOOMFIELD, CD
    BLOOD, 1993, 82 (10) : A196 - A196
  • [48] MONOCYTE AND NEUTROPHIL FUNCTION IN MYELODYSPLASTIC SYNDROMES (MDS)
    NAGLER, A
    KLETTER, Y
    OBEDEANU, N
    TATARSKY, I
    EXPERIMENTAL HEMATOLOGY, 1986, 14 (06) : 549 - 549
  • [49] Mechanism of Action of Azacytidine in Myelodysplastic Syndromes (MDS)
    Dighe, Niraja
    Venkatesan, Subhashree
    Zhiyong, Poon
    Hwang, William Y. K.
    BLOOD, 2016, 128 (22)
  • [50] Flow cytometric patterns in myelodysplastic syndromes (MDS)
    Singleton, TP
    Phadke, DM
    LABORATORY INVESTIGATION, 2002, 82 (01) : 264A - 264A